Refers to a compound of formula I, wherein R1 is H, c1-c4 alkyl R2 is H, Methyl R3 is c1-c4 alkyl substituted with one or more amino groups, 1 or More di - C1 - C4 - amino alkyl R4 is H, or R3 and R4 with piperidino n form, piperazinilo replaced or not with 1 or more c1-c4 alkyl, 1 or More groups dimeti Laminated. A Preferred Compound is (a). Also referred unacomposicion Pharmaceutical.These compounds are inhibitors of the sodium dependent Glucose Transporter 1 (SGLT1) useful in the treatment of Early Diabetes and metabolic syndromeREFERIDA A UN COMPUESTO DE FORMULA I, DONDE R1 ES H, ALQUILO C1-C4 R2 ES H, METILO R3 ES ALQUILO C1-C4 SUSTITUIDO CON 1 O MAS AMINO, 1 O MAS GRUPOS DI-ALQUIL C1-C4-AMINO R4 ES H, O R3 Y R4 JUNTO AL N FORMAN PIPERIDINO, PIPERAZINILO SUSTITUIDO O NO CON 1 O MAS ALQUILO C1-C4, 1 O MAS GRUPOS DIMETILAMINO. UN COMPUESTO PREFERIDO ES (A). REFERIDA ADEMAS UNACOMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DEL TRANSPORTADOR DE GLUCOSA DEPENDIENTE DE SODIO 1 (SGLT1) UTIL EN EL TRATAMIENTO DE INICIO DE DIABETES Y EL SINDROME METABOLICO
